Genetic Effects on miRNA Expression During Mid-Gestation Neocortical Development

SEX - Biological sex as determined by genotype array and rna-sequencing XIST expression (phv00525903.v1.p1)

ANALYTE_TYPE - Analyte type (phv00525910.v1.p1)
BODY_SITE - Body site where sample was collected (phv00525909.v1.p1)
CONSENT - Consent group as determined by DAC (phv00525902.v1.p1)
DNAPurificationMethod - DNA purification method (phv00525928.v1.p1)
FILETYPE - File type (phv00525913.v1.p1)
GenotypePlatform - DNA genotype platform (phv00525929.v1.p1)
HISTOLOGICAL_TYPE - Tissue type (phv00525912.v1.p1)
IS_TUMOR - Tumor status (phv00525911.v1.p1)
Lanes - RNA sequencing lane (phv00525921.v1.p1)
Pool - RNA sequencing pool (phv00525920.v1.p1)
ReadsPerSample - RNA reads per sample (phv00525922.v1.p1)
RIN - ERIN score (phv00525923.v1.p1)
RNA_260_230 - RNA 260 absorbance over 230 absorbance (phv00525924.v1.p1)
RNA_260_280 - RNA 260 absorbance over 280 absorbance (phv00525925.v1.p1)
RNAConcentration - RNA concentration (phv00525926.v1.p1)
RNALibraryKit - RNA library kit (phv00525915.v1.p1)
RNALibraryType - RNA library type (phv00525914.v1.p1)
RNAPurificationMethod - RNA purification method (phv00525927.v1.p1)
SAMPLE_ID - Sample ID (phv00525908.v1.p1)
SAMPLE_ID - Sample ID (phv00525905.v1.p1)
SequencingDate - RNA sequencing date (phv00525917.v1.p1)
SequencingProject - RNA sequencing project (phv00525918.v1.p1)
SequencingRun - RNA sequencing run (phv00525919.v1.p1)
SUBJECT_ID - Subject ID (phv00525901.v1.p1)
SUBJECT_ID - Subject ID (phv00525904.v1.p1)
SUBJECT_ID - Subject ID (phv00525906.v1.p1)
TruSeqBarcode - TruSeq RNA library barcode (phv00525916.v1.p1)